4//SEC Filing
SCHEDER-BIESCHIN MAX 4
Accession 0001209191-18-021763
CIK 0001549084other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:05 PM ET
Size
6.8 KB
Accession
0001209191-18-021763
Insider Transaction Report
Form 4
SCHEDER-BIESCHIN MAX
Chief Financial Officer
Transactions
- Award
Common Stock
2018-03-22+57,325→ 89,696 total - Tax Payment
Common Stock
2018-03-23$1.54/sh−17,836$27,482→ 71,860 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.56, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Documents
Issuer
EKSO BIONICS HOLDINGS, INC.
CIK 0001549084
Entity typeother
Related Parties
1- filerCIK 0001342549
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 5:05 PM ET
- Size
- 6.8 KB